O

Optus Pharmaceutical Co Ltd
KOSDAQ:131030

Watchlist Manager
Optus Pharmaceutical Co Ltd
KOSDAQ:131030
Watchlist
Price: 10 360 KRW -0.67% Market Closed
Market Cap: ₩182.9B

Optus Pharmaceutical Co Ltd
Non-Reccuring Items

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Optus Pharmaceutical Co Ltd
Non-Reccuring Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Non-Reccuring Items CAGR 3Y CAGR 5Y CAGR 10Y
O
Optus Pharmaceutical Co Ltd
KOSDAQ:131030
Non-Reccuring Items
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Suheung Co Ltd
KRX:008490
Non-Reccuring Items
-₩709.5m
CAGR 3-Years
14%
CAGR 5-Years
8%
CAGR 10-Years
N/A
SD Biosensor Inc
KRX:137310
Non-Reccuring Items
-₩134.4B
CAGR 3-Years
-289%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
B
BioPlus Co Ltd
KOSDAQ:099430
Non-Reccuring Items
₩0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
HLB Inc
KOSDAQ:028300
Non-Reccuring Items
-₩88.5m
CAGR 3-Years
67%
CAGR 5-Years
15%
CAGR 10-Years
18%
T
T&L Co Ltd
KOSDAQ:340570
Non-Reccuring Items
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Optus Pharmaceutical Co Ltd
Glance View

Market Cap
182.9B KRW
Industry
Health Care

OPTUS Pharmaceutical Co., Ltd. engages in the manufacture and sale of ophthalmic products. The company is headquartered in Cheongju, Chungcheongbuk-Do and currently employs 171 full-time employees. The company went IPO on 2010-12-03. The firm is primarily engaged in the manufacture and sale of eye drops and ophthalmic preparations such as dry eye treatment agents, conjunctivitis treatment agents, anti-inflammatory medication agents, glaucoma treatment agents and others.

Intrinsic Value
5 435.91 KRW
Overvaluation 48%
Intrinsic Value
Price ₩10 360
O

See Also

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett